ema says international regulators’ recommendations on covid-19 vaccines and the omicron variant
ema: vaccination continues to offer considerable protection from hospitalisation and severe covid-19 with omicron, especially after a booster dose
ema: it is becoming increasingly clear that a booster dose is needed to extend vaccine protection
ema says reviewing data on impact of omicron, participants concluded current vaccines offer less protection against infection and mild disease caused by omicron variant
ema: there is a need to develop a long-term strategy on the types of vaccines needed to manage covid-19 in the future
ema: meeting participants agreed that the administration of multiple booster doses at short intervals is not a sustainable approach in the longer term
ema: with respect to updated vaccine compositions, global regulators encourage developers to look at alternative approaches to monovalent vaccines
ema: in regulators’ view, cos should explore feasibility of developing bivalent or multivalent variant vaccines to determine if they offer advantages to monovalent vaccines.
